Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$24.15 - $31.95 $181,777 - $240,487
7,527 New
7,527 $218,000
Q2 2023

Aug 14, 2023

SELL
$40.4 - $59.1 $223,654 - $327,177
-5,536 Reduced 44.95%
6,781 $275,000
Q1 2023

May 15, 2023

BUY
$38.16 - $48.86 $210,337 - $269,316
5,512 Added 81.0%
12,317 $596,000
Q4 2022

Feb 14, 2023

SELL
$33.53 - $54.79 $8,382 - $13,697
-250 Reduced 3.54%
6,805 $259,000
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $19,083 - $24,555
456 Added 6.91%
7,055 $354,000
Q2 2022

Aug 15, 2022

BUY
$25.6 - $45.23 $168,934 - $298,472
6,599 New
6,599 $264,000
Q3 2021

Nov 15, 2021

SELL
$37.01 - $44.74 $177,092 - $214,080
-4,785 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$46.8 - $68.92 $46 - $68
-1 Reduced 0.02%
4,785 $227,000
Q4 2020

Feb 16, 2021

SELL
$47.96 - $67.64 $15,970 - $22,524
-333 Reduced 6.51%
4,786 $292,000
Q2 2020

Aug 13, 2020

SELL
$42.56 - $54.98 $2,170 - $2,803
-51 Reduced 0.99%
5,119 $260,000
Q1 2020

May 15, 2020

BUY
$32.37 - $59.36 $1,197 - $2,196
37 Added 0.72%
5,170 $231,000
Q4 2019

Feb 14, 2020

BUY
$32.22 - $50.07 $165,385 - $257,009
5,133 New
5,133 $247,000
Q3 2019

Nov 14, 2019

SELL
$33.82 - $48.17 $173,598 - $247,256
-5,133 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$35.42 - $45.0 $181,810 - $230,985
5,133 New
5,133 $231,000
Q1 2019

May 15, 2019

SELL
$28.09 - $39.49 $311,209 - $437,509
-11,079 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$29.83 - $46.51 $52,530 - $81,904
-1,761 Reduced 13.71%
11,079 $380,000
Q3 2018

Nov 14, 2018

BUY
$33.9 - $47.77 $23,357 - $32,913
689 Added 5.67%
12,840 $603,000
Q2 2018

Aug 14, 2018

BUY
$25.7 - $47.88 $312,280 - $581,789
12,151 New
12,151 $410,000
Q4 2017

Feb 14, 2018

SELL
$15.14 - $20.89 $299,711 - $413,538
-19,796 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$16.81 - $21.61 $332,770 - $427,791
19,796
19,796 $396,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.